Detalhe da pesquisa
1.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Eur J Immunol
; 46(4): 941-51, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683421
2.
Tissue Cytokine IL-33 Modulates the Cytotoxic CD8 T Lymphocyte Activity During Nutrient Deprivation by Regulation of Lineage-Specific Differentiation Programs.
Front Immunol
; 10: 1698, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396219
3.
Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.
Oncogene
; 38(24): 4788-4803, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30816345
4.
Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.
Front Immunol
; 8: 1242, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29033951
5.
Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.
Front Pharmacol
; 7: 412, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27857690